Palma Shaw, MD
Vascular Surgery · Syracuse, NYNPI 1639107279
Payments from drug & device makers
Across 139 payments — averaging $255.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bolton Medical Inc$12K
- Medtronic$7K
- Endologix LLC$4K
- W. L. Gore & Associates, Inc.$4K
- Silk Road Medical, Inc.$3K
- Bristol Myers Squibb$2K
- plus $4K from 17 others
What the payments were for
- Consulting fees$8,64530%
- Speaking & faculty fees$8,40029%
- Travel & lodging$8373%
- Food & beverage$10,62237%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bolton Medical Inc | 44 | $11,594 |
| Medtronic(2 entities) | 28 | $6,859 |
| Endologix LLC | 8 | $4,346 |
| W. L. Gore & Associates, Inc. | 15 | $3,851 |
| Silk Road Medical, Inc. | 8 | $3,210 |
| Bristol Myers Squibb | 1 | $1,500 |
| Inari Medical, Inc. | 5 | $1,305 |
| Philips North America LLC | 5 | $836 |
| Penumbra, Inc. | 3 | $487 |
| Shape Memory Medical Inc. | 4 | $297 |
| Cook Medical LLC | 3 | $239 |
| Boston Scientific | 2 | $228 |
| Surmodics, Inc. | 1 | $159 |
| Organogenesis Inc. | 2 | $140 |
| Shockwave Medical, Inc | 1 | $135 |
| Asahi Intecc USA, Inc. | 1 | $118 |
| Convatec Inc. | 2 | $77 |
| Abbott | 1 | $70 |
| EKOS Corporation | 1 | $30 |
| 180 Medical, Inc. | 1 | $28 |
| Lemaitre Vascular, Inc. | 1 | $21 |
| Advanced Oxygen Therapy Inc. | 1 | $19 |
| Polymedics Innovations Inc. | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENDURANT IIS$5,963
- Relay Grafts$3,766
- ENROUTE Transcarotid Neuroprotection System$2,954
- ENROUTE Transcarotid Stent$2,954
- GORE EXCLUDER AAA Endoprosthesis$2,182
- Alto Abdominal Stent Graft System$2,115
- GORE EXCLUDER Iliac Branch Endoprosthesis$1,995
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$1,995
- ENHANCE Transcarotid Peripheral Access Kit$1,604
- ENROUTE .014 Guidewire$1,604
- FLOWTRIEVER CATHETER, S$1,286
- CT THROMBECTOMY SYSTEM KIT$1,286
- US Und$722
- GORE VIABAHN VBX Balloon Expandable Endo$521
- TREO ABDOMINAL STENT-GRAFT SYSTEM$515
- Relay Plus$371
- Indigo System$298
- IMPEDE EMBOLIZATION PLUG$280
- Grafts$267
- Torus Stent Graft System$240
How this compares
$35,554 in reported general payments places this provider in the 80th percentile of 405 vascular surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cilostazol | 38 | $601 |
| ClopidogrelClopidogrel Bisulfate | 14 | $112 |
| Atorvastatin Calcium | 15 | $37 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Syracuse
- Anthony FeghaliSyracuse$224K
- Gary GelbfishNew York$1.9M
- Sundaram RavikumarDobbs Ferry$1.8M
- Antonios GasparisHuntington$1.7M
- John LantisNew York$1.4M
- Sonya NoorBuffalo$1.2M
- Brian DerubertisNew York$1M
- Thomas MaldonadoNew York$1M
- James McKinseyNew York$750K
- Peter FariesNew York$639K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.